Prognostic Value of miR-145 in HER2-Positive Locally Advanced or Metastatic Urothelial Carcinoma Treated with Disitamab Vedotin. Li B, Li D, Deng N, Liu P, et al. Cancer Invest 2026;44:1008-1016.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li B, Li D, Deng N, Liu P, et al. Prognostic Value of miR-145 in HER2-Positive Locally Advanced or Metastatic Urothelial Carcinoma Treated with Disitamab Vedotin. Cancer Invest 2026;44:1008-1016.
PMID: 42226682